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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYHuman bone marrow (BM) contains a rare population of nonhematopoietic mesenchymal stromal cells (MSCs), which are of central
importance for the hematopoietic microenvironment. However, the precise phenotypic definition of these cells in adult BM has not
yet been reported. In this study, we show that low/negative expression of CD140a (PDGFR-a) on lin/CD45/CD271+ BM cells identified
a cell population with very high MSC activity, measured as fibroblastic colony-forming unit frequency and typical in vitro and in vivo
stroma formation and differentiation capacities. Furthermore, these cells exhibited high levels of genes associated with mesenchymal
lineages and HSC supportive function. Moreover, lin/CD45/CD271+/CD140alow/ cells effectively mediated the ex vivo expansion
of transplantable CD34+ hematopoietic stem cells. Taken together, these data indicate that CD140a is a key negative selection marker
for adult human BM-MSCs, which enables to prospectively isolate a close to pure population of candidate human adult stroma stem/pro-
genitor cells with potent hematopoiesis-supporting capacity.INTRODUCTION
Human bone marrow (BM) contains—besides the well-
known hematopoietic stem cells (HSCs)—a population
of nonhematopoietic mesenchymal stromal cells (MSCs),
which are multipotent and can differentiate toward
skeletal lineages in vivo (Sacchetti et al., 2007). In vitro,
clonogenic cells, which are denoted as colony-forming
unit-fibroblasts (CFU-Fs) (Friedenstein et al., 1970), can
be assayed from the BM as plastic adherent cells giving
rise to fibroblastic colonies. These CFU-F cells are consid-
ered to reflect the primary BM-MSC, and upon further
proliferation in culture, their descendants make up the
extensively studied cultured MSCs (Keating, 2012).
BM-MSCs are able to generate hematopoietic stroma
upon transplantation in vivo, thus providing the special-
ized microenvironments for HSCs (Sacchetti et al., 2007).
Furthermore, BM-MSCs have been shown to play an
important role in regulating self-renewal and differentia-
tion of HSCs (Me´ndez-Ferrer et al., 2010), and they have
also been implicated in the development of hematological
malignancies (Raaijmakers et al., 2010).
However, the precise in vivo identity and phenotypic
signature of adult BM-MSCs have thus far remained elusive
(Keating, 2012). Therefore, this current study aimed for a
precise phenotypic characterization of the human BM stro-
mal cell population by utilizing comparative gene expres-
sion profiling as a screening tool. Based on this screening,Stem Celllow/negative expression of CD140a (PDGFR-a) was identi-
fied as the key feature that enabled the isolation of a close to
pure population of primary MSC in adult human BM non-
hematopoietic CD271+ cells. In contrast, human fetal BM-
MSCs were recently reported to be CD140a positive (Pinho
et al., 2013), indicating that PDGFR-a expression is regu-
lated developmentally.
RESULTS AND DISCUSSION
Comparative Gene Expression Analysis of lin/
CD45/CD271+ versus lin/CD45/CD271 BM Cells
Identifies Human MSC Markers
We and others have shown that CFU-Fs were highly and
exclusively enriched only in lin/CD45/CD271+ BM
cells but not in the CD271 fraction (Churchman et al.,
2012; Tormin et al., 2011). Therefore, an array-based
gene expression analysis was performed comparing these
two cell populations as a screening tool to identify poten-
tial MSC surface markers (the sorting strategy is presented
in Figure S1 available online). In total, 219 genes were
significantly upregulated in the CD271+ subset, including
typical MSC genes as well as genes encoding for cyto-
kines, growth factors, and extracellular matrix proteins
(Table S1).
Twenty-eight upregulated genes were related to surface-
expressedmolecules (Figure 1A; Table S2). Only eight genes
were cell surfacemarkers that had been previously reportedReports j Vol. 3 j 965–974 j December 9, 2014 j ª2014 The Authors 965
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PDGFR-a Expression on Human Adult BM-CFU-Fto be expressed on primary MSCs, i.e., LEPR/CD295,
TGFBRIII, CDH11, and FGFRIII (Churchman et al., 2012);
CD140b, CD10, CD106 (Battula et al., 2008; Bu¨hring
et al., 2007; Gronthos et al., 2003); and CD140a (Pinho
et al., 2013). The remaining 20 genes, of which four were
selected for validation by quantitative RT-PCR confirming
the results of the gene array (Figure 1B), had not been re-
ported in the context of MSC isolation.
Cell-Surface Expression Analysis of Potential MSC
Markers on lin/CD45/CD271+ Cells
Next, protein expression was validated for those candidate
surface markers for which antibodies were commercially
available. Lin/CD45/CD271+ cells expressed high levels
of CD10, CD140b, CD81, leptin receptor (LEPR), trans-
forming growth factor beta receptor III (TGFBRIII), inter-
leukin 1 receptor alpha (IL1R1), CD106, and CD151,
while expression of CD18, interferon gamma receptor 2
(IFNGR2), cadherin-11 (CDH11), transforming growth fac-
tor beta receptor II (TGFBRII), CD140a, and fibroblast
growth factor receptor 3 (FGFR3) was low/intermediate
(Figures 1C and 1D). TNFR1 was the only candidate gene
for which measurable protein expression levels were not
detected (data not shown).
Most of the identified markers showed a staining pattern
that paralleled CD271 expression; i.e., expression levels of
the newly discovered marker increased with increasing
CD271 levels (group I markers; Figure 1C). Therefore, these
markers would not be expected to improve CFU-F enrich-
ment in sorted CD271+ cells. Accordingly, experiments
using CD151 as an example (Figure 1C, lower panel),
demonstrated that CFU-F frequencies were not signifi-
cantly different compared with isolation based on CD271
and other knownMSCmarkers, such as CD106 (Figure 1C,
lower panel; Figure S2A). As expected, sorted lin/CD45/
CD271+/CD151+ cells showed all typical MSC properties
in vitro (Figures S2A–S2F) and in vivo, i.e., formation ofFigure 1. Gene Expression Analysis Identifies MSC Surface Marker
Population
(A) Heatmap of significantly upregulated surface molecule genes in li
(B) Quantitative RT-PCR of lin/CD45/CD271 compared with CD271
with GAPDH levels. Data are from three individual experiments with d
(C and D) Lineage depleted BM-MNCs were stained with antibodies as
CD271 expression (x axis) versus expression of the indicated marker (y
of dead cells (7-AAD), and gating on CD45-negative cells. Sorting ga
plots (D).
(E) CFU-F frequencies of primary lin/CD45/CD271+ BM cell populat
data (dots) from bulk sorting (left plot, n = 5–11 independent experim
independent limiting dilution experiments with seven different cell c
represents the average of the three experiments). Single cell sorting da
given as mean ± SD (middle plot). The sorting strategy is illustrated
See also Figures S1 and S2 and Tables S1, S2, and S3.
Stem Cellhuman MSC-derived bone, stroma invaded by murine he-
matopoietic cells, and an increase in vessel density (Figures
S2G–S2I). LEPR is another group I marker that was recently
reported to identify the majority of CFU-F in adult murine
BM (Zhou et al., 2014). Our data showed that LEPR expres-
sion is conserved; i.e., that the majority of human adult
CFU-F is contained in the LEPR+ fraction (Figure S2J).
Group II Marker CD140a, but Not FGFR3, Allows
Isolation of a Close to Pure Population of CFU-F-
Initiating Cells
On the other hand, CD140a and FGFR3 (group II markers)
showed a more orthogonal staining pattern, allowing us
to identify subpopulations of CD140a+, CD140alow/ and
FGFR3+, FGFR3low/ cells, respectively (Figure 1D).
Whereas sorting based on FGFR3 expression did not
improve CFU-F enrichment (data not shown), very high
CFU-F frequencies were observed when CD271+ cells were
sorted according to low/negative CD140a expression (Fig-
ure 1E). Mean CFU-F frequencies in bulk cultures seeded
at clonal densities were as high as 20.8 ± 9.6 CFU-F per
100 cells in the CD140alow/ fraction compared with 0.8
± 1.2 CFU-F per 100 plated CD140a+ cells and 0.8 ± 0.8
CFU-F per 100 plated CD271+ cells (Figure 1E, left graph).
Similar results were obtained by single cell assays and
limiting dilution analysis (Figure 1E, middle and right
graphs, respectively). Considering that the high frequency
of progenitor activity corresponds well to that reported for
other immunophenotypically defined stem cell popula-
tions, such as HSCs, lin/CD45/CD271+/CD140alow/
cells are likely to represent a (close to) pure population of
primary MSCs in human adult BM.
Recently, Mabuchi et al., (2013) reported comparable
CFU-F frequencies by using a direct two-marker isolation
approach (CD271, CD90). However, experiments in their
study were performed with femoral bone fragments, which
contain only few hematopoietic cells. In contrast,s of which CD140a Enables Isolation of a Highly Enriched CFU-F
n/CD45/CD271+ versus lin/CD45/CD271 cells of five donors.
+ cells. Results are shown as mRNA fold change after standardizing
uplicate measurements for each of the genes. *p < 0.05.
indicated and analyzed by flow cytometry. Representative plots of
axis) are shown after forward-scatter/side-scatter gating, exclusion
tes are indicated in the CD106, CD151 (C), and CD140a and FGFR3
ions sorted on CD140a expression. Data are presented as individual
ents with at least three replicates for each experiment), and three
oncentrations for each experiment (right plot, each dot in the plot
ta were calculated from three independent experiment, and data are
in Figure S3. *p < 0.05.
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Figure 2. Properties of Primary and Cultured CD45/CD271+/CD140alow/ Cells
(A) Cytospin preparations of CD45/CD271+/CD140alow/ and CD45/CD271+/CD140a+ cells (May-Gru¨nwald/Giemsa staining). Scale bars
represent 20 mm.
(B) FACS analysis of primary lin/CD45 BM-MNC. Events are plotted for CD271 (x axis) against CD140a (y axis) expression. Red events
indicate cells that coexpressed the marker listed on top, i.e., CD105, CD90, CD140b, STRO-1, CD31, CD34, SSEA4, and CD34, respectively,
whereas gray events indicate lack of coexpression. One representative set of FACS plots of a total of three experiments is shown.
(legend continued on next page)
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PDGFR-a Expression on Human Adult BM-CFU-Fhematopoietically active BM as used in our study contains
CD90+ hematopoietic cells, and CFU-F activity is also de-
tected in CD90 cells (data not shown), which indicates
that the CD271/CD90 two-marker approach is not suitable
to enrich CFU-F from standard BM aspirations.
Primary lin/CD45/CD271+/CD140alow/ Cells
Exhibit a Typical BM-MSC Phenotype and Give Rise to
Typical Cultured MSCs
Cytospin preparations of lin/CD45/CD271+/CD140alow/
and CD140a+ cells showed a typical MSC morphology
with cytoplasmic vacuoles and large, immature nuclei (Fig-
ure 2A). Furthermore, lin/CD45/CD271+/CD140alow/
cells expressed signature MSC markers, such as CD90,
CD105, CD140b, and STRO-1 while lacking expression of
CD31, CD34 (Figure 2B). As reported previously (Tormin
et al., 2011), SSEA-4 andGD2were not detected on primary
BM-MSCs (Figure 2B), whichmight be due to differences in
experimental protocols. Among lin/CD45/CD271+ cells,
expression of pluripotency genes (Nanog, Oct4, Sox2) and
cyclin-dependent kinase inhibitor gene p16 was higher in
CD140alow/ than in CD140a+ cells (Figure 2C). Compara-
ble gene expression was observed for differentiation genes
(ALPL, PPARg, ACAN), p21, and decoy receptor 2 (DCR2).
Furthermore, short-term differentiation induction experi-
ments (24 hr) increased expression of PPARg and ACAN
only in CD140alow/ MSCs but not in CD140+ cells (data
not shown). Cell cycle distributions of CD140a+ and
CD140alow/ cells were not significantly different, but a
trend was observed toward more quiescent CD140a cells
(Figure 2D). These data indicate that CD140alow/ MSCs
represent a distinct population of immature, quiescent
stem/progenitor cells with multilineage potential.
Stromal cell cultures generated from sorted lin/CD45/
CD271+/CD140alow/ cells (single-cell as well as bulk) were
composed of typical adherent, spindle-shaped, fibroblastic-
like cells (Figure 2E), with a typicalMSC surfacemarker pro-(C) Quantitative RT-PCR was performed on sorted lin/CD45/CD271
shown as mRNA fold change after standardizing with GAPDH levels. D
experiments with duplicate measurements for each of the genes. *p
(D) Cell cycle analysis of the CD45/CD271+/CD140alow/ and CD45/
experiments).
(E) Morphology of colonies derived from CD45/CD271+/CD140alow/
(F) Flow cytometric analysis of MSC marker expression of CD45/CD
corresponding isotype controls (red line). A representative set of dat
(G) In vitro differentiation capacity of stromal cells derived from bul
adipogenic, and chondrogenic lineage (upper panel). Controls are sh
100 mm (adipocyte), and 200 mm (chondrocyte). A representative se
(H) Multiclonal cultures generated from CD45/CD271+/CD140alow/ c
NOD/SCID mice. Representative sections 8 weeks after transplantatio
capillaries (*) are indicated (magnification 103). Blowups are shown
and megakaryocytes (lower blowup) could be detected. Scale bar rep
See also Figures S3 and S4 and Table S3.
Stem Cellfile (Figure 2F). Interestingly, CD140a expression increased
in culture, which might be influenced by cell attachment,
cell density, and culture medium composition. Lin/
CD45/CD271+/CD140a+ cells did not generate sufficient
colonies for further studies. In contrast, CD140alow/-
derived cultured stromal cells demonstrated robust multili-
neage differentiation potential in vitro (Figure 2G). This
was not only observed in multiclonal cultures from bulk-
sorted cells, but also in single-cell-derived clones, of which
62%, 31%, and 7% exhibited trilineage, bilineage, and
unilineage differentiation potential, respectively. Finally,
in vivo differentiation potential was tested by subcutane-
ous implantation of lin/CD45/CD271+/CD140alow/-
derived cells into immunodeficient mice. In addition
to bone, adipocytes, and stromal tissues, invading he-
matopoietic cells were clearly identified in the ectopic scaf-
folds (Figure 2H). These results thus demonstrate that
CD140alow/ cells have the capacity to generate hemato-
poietic stroma in vivo, a key property of primary BM-
MSCs (Sacchetti et al., 2007).
Hematopoiesis-Supporting Capacity of lin/CD45/
CD271+/CD140alow/ Cells
We have recently shown that primitive BM-MSCs promote
the ex vivo expansion of human umbilical cord blood (CB)-
derived CD34+ cells (Isern et al., 2013). These results
prompted us to assess the hematopoiesis-supporting capac-
ity of lin/CD45/CD271+/CD140alow/ cells in coculture
assays with CB CD34+ cells. CD34+ hematopoietic cells
were evenly distributed and in close contact with the feeder
cells only when cocultured with the lin/CD45/CD271+/
CD140alow/ cells and their stromal derived progeny, i.e.,
cultured mesenchymal stroma cells (cMSCs) (Figures 3A
and 3B). CD271/CD140a+ cells did not form confluent
feeder layers, and thus, CD34+ cocultures showed a similar
distribution pattern as the nonfeeder cell cultures
(Figure 3A).+/CD140a+ and lin/CD45/CD271+/CD140alow/ cells. Results are
ata are given as mean ± SD. Data are from three to eight individual
< 0.05.
CD271+/CD140a+ cells by KI67 and DNA staining (n = 3 independent
cells (crystal violet staining). Scale bar represents 200 mm.
271+/CD140alow/-derived cultured stromal cells (blue line) and
a of a total of three experiments is shown.
k-sorted CD45/CD271+/CD140alow/ cells toward the osteoblastic,
own in the lower panel. Scale bars represent 500 mm (osteoblast),
t of pictures from a total of three experiments is shown.
ells were transplanted subcutaneously (with HA/TCP particles) into
n are shown. Bone (b), adipocytes (a), fibroblastic tissue (ft), and
at 603magnification. Invading hematopoietic cells (upper blowup)
resents 20 mm.
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PDGFR-a Expression on Human Adult BM-CFU-FOne week coculture with lin/CD45/CD271+/
CD140alow/ cells increased total cell production in cyto-
kine-supported expansion cultures (Figure 3C), which
was comparable with cMSC as feeder cells. Moreover, the
number of CD34+ cells was the best in lin/CD45/
CD271+/CD140alow/ supported cultures (Figure 3D),
which showed a better preservation of the CD34+ pheno-
type compared with cMSC (Figure 3E). Correspondingly,
lin/CD45/CD271+/CD140alow/ cells showed high
expression of hematopoiesis-supporting genes (VCAM1,
SPP1, CXCL12, and angiopoietin 1; Figure 3F). CD34+ cells
expanded on lin/CD45/CD271+/CD140alow/ feeder
cells or cMSCs were capable of efficient long-term hemato-
poietic multilineage reconstitution in immunodeficient
mice (Figure 4).
CD140a, which is a long-known marker for murine
MSCs, has only recently been reported as a positive marker
to identify human fetal BM CFU-F-initiating cells (Pinho
et al., 2013). However, adult BM cells are by far the
most commonly used MSC source, and our data clearly
demonstrate that MSCs are highly enriched within the
CD140alow/ population but not in CD140+ cells. This dis-
tribution pattern is also observed in older adults, even
though CFU-F frequencies in CD140alow/ cells are lower
(Figure S4). On the other hand and consistent with previ-
ous work (Pinho et al., 2013), we found that fetal
CD140a+ cells had an increased CFU-F frequency, clearly
contrasting the results in adult BM cells. These data suggest
that CD140a expression is progressively downregulated
during development, which was also supported by exami-
nation of the CD140a expression of murine BM-MSCs at
different developmental stages (Figure S4D).
Platelet-derived growth factor (PDGF) is a key signaling
molecule in the complex bone formation process and
a powerful mitogen and chemoattractant for MSCs,
inducing proliferation as well as affecting directional
mobility (Caplan and Correa, 2011). Increased PDGFR-a
signaling in embryos leads to hyperplasia of stromal fibro-
blasts (Olson and Soriano, 2009). The MSC enrichment in
the CD140a+ fraction during bone development and itsFigure 3. CD45/CD271+/CD140alow/ Cells Promote the Ex Vivo
(A) Representative pictures of individual culture wells. HSCs indicate
(B) Photomicrograph illustrating CB CD34+ coculture on CD45/CD27
(C and D) Total number of hematopoietic cells (C) and CD34+ cells (
individual experiments and provided as mean ± SD (n = 3). *p < 0.05
(E) Representative FACS profile of coculture-generated cells.
(F) Quantitative RT-PCR of sorted lin/CD45/CD271+/CD140a+ and l
fold change after standardizing with GAPDH levels. Data are given as m
measurements for each of the genes. *p < 0.05.
CB CD34+ cells were cocultured for 1 week with CD45/CD271+/CD140
standard cultured stromal cells (cMSCs). Cultures were supplemente
(reduced or high cytokines). See also Table S3.
Stem Cellprogressive downregulation strongly suggest that it might
be required for osteoprogenitor activity possibly also under
pathological conditions, but our results suggest that this
receptor may not necessarily be essential for the HSC niche
function of BM-MSCs.
In summary, based on comparative gene expression anal-
ysis, we could demonstrate that low/negative expression of
CD140a identified a close to pure population of the puta-
tive stromal stem/progenitor cells in human adult BM,
which is likely to be a critical first step toward a better func-
tional characterization of these important constituents of
the hematopoietic microenvironment.EXPERIMENTAL PROCEDURES
BM Mononuclear Cells
A total of 111 BM samples were collected from 87 healthy adult
donors (median age, 25 years; range 19–41) plus three additional
older donors (52, 56, and 61 years). BM (60 ml) was aspirated
from the iliac crest bone of consenting healthy donors. BM aspi-
ration was approved by the local ethics committee. BM-MNCs
were isolated by density gradient centrifugation (LSM 1077
Lymphocyte; PAA) with or without prior incubation with Roset-
teSep Human MSC Enrichment Cocktail (StemCell Technologies)
for lineage depletion (CD3, CD14, CD19, CD38, CD66b, glyco-
phorin A). The preparation of fetal BM cells is described in
Figure S3.
Generation of Cultured MSCs and CFU-F Assays
Sorted BM-MNCs were cultured in standard MSC culture medium
(NH Expansion Medium; Miltenyi Biosciences) and passaged as
described (Tormin et al., 2011). CFU-F assays were performed as
before (Tormin et al., 2011); a detailed description is provided in
the Supplemental Experimental Procedures.
Microarray Expression Analysis
RNA from sorted cell populations was isolated, amplified, and
analyzed for gene expression microarray analysis using Illumina
HumanHT-12 expression v4 BeadChips (Illumina). Detailed exper-
imental procedures and data analysis are described in the Supple-
mental Experimental Procedures.Expansion of CB CD34+ Cells
well with CD34+ cells that were cultured without stromal support.
1+/CD140a low/ stromal cells. Scale bar represents 200 mm.
D) produced after 1-week culture. Data are calculated from three
.
in/CD45/CD271+/CD140alow/ cells. Results are shown as mRNA
ean ± SD. Data are from three individual experiments with duplicate
alow/, CD45/CD271+/CD140a+, CD45/CD271/CD140a cells or
d with SCF, TPO, and Flt3L at concentrations of 25 or 100 ng/ml
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Figure 4. Engraftment Capacity of CB
CD34+ Cells Ex Vivo Expanded on CD45/
CD271+/CD140alow/ Feeder Cells
Analysis of human hematopoietic cell
engraftment following intravenous trans-
plantation of the culture equivalent of 50,000
input CD34+ cells into NSG mice. CB blood
CD34+ cells were cocultured for 1 week with
or without feeder cells in cytokine-supple-
mented medium (SCF, TPO, Flt3L at 25 ng/ml).
Engraftment was assessed after 8, 12, and
16 weeks using human-specific CD45 anti-
bodies (A and B) and CD15/CD33/CD66 and
CD19 antibodies (C). Representative FACS
plots are shown. Data in (B) represent the
mean ± SD of a total of four to six mice per
time point.
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Lineage-depleted BM-MNCs were incubated in blocking buffer
(Dulbecco’s PBS [DPBS] without Ca2+, Mg2+, 3.3 mg/ml human
normal immunoglobulin [Octapharma], 1% fetal bovine serum
[Life Technologies]), followed by staining with monoclonal an-
tibodies against CD45, CD151, CD140a, and CD271 (for
detailed information on all antibodies used in this study,
please see the Supplemental Experimental Procedures). Sorting
gates were set according to the corresponding fluorescence-
minus-one controls. Cells were sorted on fluorescence-acti-
vated cell sorting (FACS) Aria I or FACS Aria III cell sorters
(BD Bioscience). Dead cells were excluded by 7-amino-actino-
mycin staining (7-AAD; Sigma), and doublets were excluded
by gating on forward scatter height versus forward scatter
width and side scatter height versus side scatter width. Flow
cytometry analysis is described in the Supplemental Experi-
mental Procedures.
In Vitro Differentiation Assays
Cultured MSCs were differentiated toward the adipogenic,
osteoblastic, and chondrogenic lineages as described previously
(Tormin et al., 2011). Briefly, cells were cultured for 14 days in
AdipoDiff medium (Miltenyi) and were stained with Oil red O
(Sigma). For osteogenic differentiation, cells were cultured in os-
teogenesis induction medium (see the Supplemental Experi-
mental Procedures) for 21 days and stained with alizarin red
(Sigma). Chondrogenic differentiation was induced by culturing
cell pellets (2.5 3 105 cells/pellet) for 56 days in chondrogenesis-
induction medium (see the Supplemental Experimental Proce-
dures). Cryosections of paraformaldehyde-fixed pellets were
stained against aggrecan as described previously (Tormin et al.,
2011). Nuclei were stained with 40,6-diamidino-2-phenylindole
(Life Technologies). Sections were analyzed with an Axiovert
200M fluorescence microscope and an AxioCam HRm (both
from Carl Zeiss).
Quantitative RT-PCR
RNA from sorted lin/CD45/CD271+/CD140alow/ and lin/
CD45/CD271+/CD140a+ and lin/CD45/CD271+/CD151+ pop-
ulations was isolated from at least three individual donors. cDNA
was synthesized and quantitative RT-PCR analysis was performed
(for more details and primers, see Supplemental Experimental Pro-
cedures and Table S3).
In Vivo Bone and Stroma Assay
For analysis of in vivo bone and stroma formation, cells were cul-
ture derived from sorted CD45/CD271+/CD140alow/ and
CD45/CD271+/CD151+ cells from three different donors. Cells
were loaded overnight on hydroxyapatite/tricalcium phosphate
(HA/TCP) ceramic powder and implanted subcutaneously into 8-
week-old female nonobese diabetic/severe combined immunodefi-
ciency (NOD/SCID) mice (53 105 cells, four implants per culture).
Implants were removed after 8 weeks, fixed, decalcified, and
paraffin embedded. Sections were stained with hematoxylin/eosin
and analyzed as described (Abdallah et al., 2008). All animal proce-
dures were approved by the local ethical committees on animal
experiments.Stem CellCD34+ Cells Isolation from CB
Umbilical CB samples were obtained from full-term, normal deliv-
eries with informed consent in accordance with institutional
guidelines and as approved by the local ethical committee. Isola-
tion and enrichment of CD34+ cells from CB samples were carried
out on mononuclear cells by magnetic-activated cells sorting (Mil-
tenyi) according to manufacturer’s instructions. Cells were subse-
quently frozen in freezing buffer (90% fetal calf serum plus 10%
DMSO).
Coculture of CB CD34+ Cells with BM-MSCs
Different FACS-sorted primary BM stromal cell populations or
culture-derived MSCs (third or fourth passage) were plated into
96-well plates at 1,000 cells per well and cultured in nonhemato-
poietic medium for 7–10 days. Then medium was removed, and
5,000 CB CD34+ cells were added onto the adherent stromal cells
in serum-free expansion medium (StemCell Technologies) supple-
mented with 25 or 100 ng/ml of stem cell factor (SCF), thrombo-
poietin (TPO), and FLT3-ligand (FLT3L) (all from Peprotech). Cells
were harvested, counted, and analyzed after 1 week of coculture.
In Vivo HSC Repopulation Assay
Eight- to 12-week old femaleNOD.Cg-PrkdcscidIl2rgtmlWjl/SzJ (NOD/
SCID-IL2Rgc null; NSG) mice (Jackson Laboratory) were suble-
thally irradiated (300 cGy) 24 hr prior to transplantation. CB
CD34+ cells were cultured for 1 week in cytokine-supported
serum-free medium (25 ng/ml of SCF, TPO, and FLT3L) with or
without feeder cells (no cells, short-term cultured CD45/
CD271+/CD140alow/ cells, or fourth passage cultured MSCs,
respectively). Noncultured CB CD34+ cells served as an additional
control. The culture equivalent of 50,000 input CD34+ cells was
intravenously injected, and human engraftment was assessed 8,
12, and 16 weeks after transplantation by flow cytometry (hu-
man-specific antibodies against CD45, CD15/CD33/CD66b, and
CD19). All animal experiments were approved by local animal
ethics committee, Lund University.
Statistical Analysis
Data are expressed as mean ± SD. For a comparison of two samples,
the two-tailed Student’s t test was used. For multiple comparisons,
data were analyzed by one-way ANOVA using the Bonferroni post-
test. Differences are reported significant when p < 0.05.
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